investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Development of covalent PIP4K2 inhibitors for the treatment of p53 deficient lung tumors

Nathanael Schiander Gray

0 Collaborator(s)

Funding source

National Institutes of Health (NIH)

No posts

Related projects

David A Barbie

Targeting the cytokine circuitry of KRAS-driven lung cancer

Trachea, bronchus and lung

Simon D Spivack

Risk for Lung Cancer Asthma and COPD; Integrating Clinical and Airway Biomarker

Trachea, bronchus and lung

Srikumar P. Chellappan

TBK1 mediated regulation of E2F1 as a therapeutic target in non-small cell lung cancer

Trachea, bronchus and lung

Charles M. Rudin

Identification and validation of synthetic lethality in KRAS mutant lung adenocarcinoma patient derived xenografts

Trachea, bronchus and lung

Bruce E. Johnson

EGFR Mutations in Non-Small Cell Lung Cancer

Trachea, bronchus and lung

Mizuki Nishino

CT Volume Measurement of Lung Cancer treated with Erlotinib: Genomic Correlation

Trachea, bronchus and lung

Lesley Katie Seymour

LACE-Bio-II: Identification, Validation and Implementation of Prognostic and/or P

Trachea, bronchus and lung

Pathology

Sherry L Emery

Tobacco Control in a Rapidly Changing Media Environment

Trachea, bronchus and lung

Patricia Steeg

Molecular Biology of the Metastatic Phenotype

Trachea, bronchus and lung

Pathology